Mariner, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mariner, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$3,584,000
+10.2%
82,334
+10.3%
0.02%
+25.0%
Q1 2022$3,253,000
+13.1%
74,670
+14.5%
0.01%0.0%
Q4 2021$2,875,000
+44.1%
65,194
+24.9%
0.01%
+20.0%
Q3 2021$1,995,000
+13.3%
52,199
+18.0%
0.01%
-9.1%
Q2 2021$1,761,000
+12.2%
44,223
+0.6%
0.01%0.0%
Q1 2021$1,569,000
-6.8%
43,959
-3.9%
0.01%
-15.4%
Q4 2020$1,683,000
-8.3%
45,722
-6.2%
0.01%
-23.5%
Q3 2020$1,835,000
-14.1%
48,756
-6.9%
0.02%
-19.0%
Q2 2020$2,137,000
+23.5%
52,388
+14.5%
0.02%
-4.5%
Q1 2020$1,730,000
-11.5%
45,766
+10.0%
0.02%
+10.0%
Q4 2019$1,955,000
+10.4%
41,598
+0.2%
0.02%
-4.8%
Q3 2019$1,771,000
+32.1%
41,496
+23.8%
0.02%
+31.2%
Q2 2019$1,341,000
+199.3%
33,519
+212.9%
0.02%
+166.7%
Q1 2019$448,000
+61.7%
10,712
+47.9%
0.01%
+20.0%
Q4 2018$277,000
-2.5%
7,242
+2.5%
0.01%
-28.6%
Q3 2018$284,000
-2.7%
7,066
-2.5%
0.01%
-12.5%
Q2 2018$292,000
+9.4%
7,247
+6.0%
0.01%
-20.0%
Q1 2018$267,000
-42.9%
6,835
-36.8%
0.01%
-56.5%
Q3 2016$468,000
+66.0%
10,809
+104.6%
0.02%
-34.3%
Q4 2013$282,000
+14.6%
5,284
+7.8%
0.04%
-22.2%
Q3 2013$246,000
+3.4%
4,901
+2.9%
0.04%
-10.0%
Q2 2013$238,0004,7620.05%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders